- This event has passed.
BIOSECURE 2025, Nov. 20
November 20 @ 12:00 pm - 1:00 pm
Taking a page out of playbook used to establish the framework that excludes products of certain Chinese telecommunications companies from the federal market (e.g., the “Huawei ban”), the BIOSECURE Act would prohibit the federal government from obtaining biotechnology equipment or services from certain “biotechnology companies of concern,” including Chinese biotechnology companies. Its restrictions are designed to affect Federal contractors and to reach down into the supply chain. While BIOSECURE was originally introduced last year and did not make it into law, an updated 2025 version of the legislation has made it into the Senate version of the NDAA for FY 2026. With widespread bipartisan support, it is quite possible that BIOSECURE will be signed into law before the end of this year.
Please join the Coalition for a webinar on November 20 from 12:00 PM – 1:00 PM (ET) as we host attorneys from Hogan Lovells’ Global Regulatory practice. During this timely webinar, the Hogan Lovells team of Joy Sturm, Mike Druckman, Timothy Bergreen, and Ashley Roberts will outline what Federal contractors need to know about the Act, covering key terminology and its scope of applicability. They will also speak to the broader geopolitical context driving the legislation and its implications within the biotechnology sector.
To register, click here. If you have any questions about registration, please contact Mady Whiting at Mady.Whiting@thecgp.org.